International Centre for Diarrhoeal Disease Research, Bangladesh
Quick facts
Marketed products
- Bivalent OPV 2 week interval · Immunology
Bivalent OPV provides immunization against poliovirus types 1 and 3 by stimulating the immune system to produce antibodies against these two serotypes. - Bivalent OPV 4 week interval
- Fractional IPV( fIPV) · Immunology / Infectious Disease
Fractional IPV (fIPV) is a reduced-dose inactivated polio vaccine that provides immunological protection against poliovirus while using a smaller antigen quantity per dose. - Hepa-B · Immunology / Infectious Disease
Hepa-B is a hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B virus infection. - Hexavalent vaccine · Immunology
A hexavalent vaccine that provides immunization against six infectious diseases by stimulating the immune system to produce antibodies and cellular immunity against multiple pathogens. - Hypo-osmolar ORS
- JE Vaccine existing facility · Infectious Disease / Immunology
JE Vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus. - JE vaccine new plant lot 1 · Immunology
JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus. - JE vaccine new plant lot 2 · Immunology
JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus. - JE vaccine new plant lot 3
- Mitefosine · Other
- Monovalent OPV 2 week interval
- Monovalent OPV 4 week interval
- Oral Polio Vaccine · Immunology / Infectious Disease
Oral Polio Vaccine stimulates the immune system to produce antibodies against poliovirus by delivering live attenuated (weakened) poliovirus strains orally. - Pentavalent vaccine
- Pneumococcal protein vaccine · Immunology
This vaccine stimulates the immune system to produce antibodies and cellular immunity against pneumococcal protein antigens, preventing infection by Streptococcus pneumoniae. - polio vaccines: nOPV2, bOPV, IPV
- Quadrivalent Influenza Vaccine · Immunology
This vaccine works by stimulating the body's immune system to produce antibodies against influenza viruses. - Rotavirus Vaccine (ROTARIX) · Immunology / Infectious Disease
ROTARIX is a live attenuated rotavirus vaccine that stimulates the immune system to produce antibodies and cellular immunity against rotavirus infection. - Trivalent OPV 4 week interval · Immunology / Infectious Disease
Trivalent OPV provides immunization against three serotypes of poliovirus (types 1, 2, and 3) by inducing mucosal and systemic immune responses through oral administration of live attenuated virus.
Phase 3 pipeline
- Amylase resistant starch added ORS · Gastroenterology / Infectious Disease
Amylase-resistant starch in oral rehydration solution reduces stool output and improves water absorption in diarrheal disease by providing a slowly fermentable carbohydrate substrate. - Blood and adrenaline · Cardiovascular
This drug stimulates the release of adrenaline and increases blood flow to vital organs. - Blood and Dopamine
Unknown mechanism; the drug name suggests potential involvement in blood regulation and dopaminergic pathways, but specific molecular action is not established. - Measles and Rubella (MR) · Immunology / Infectious Disease
The MR vaccine stimulates the immune system to produce antibodies and cellular immunity against measles and rubella viruses through live attenuated viral antigens. - Oral Cholera Vaccine (OCV) · Infectious Diseases
The Oral Cholera Vaccine (OCV) works by stimulating the body's immune system to produce antibodies against Vibrio cholerae, the bacteria that causes cholera. - Rotavirus Vaccine & Breastfeeding · Infectious Diseases
The Rotavirus Vaccine works by stimulating the body's immune system to produce antibodies against rotavirus, thereby preventing infection. - Shanchol vaccine · Infectious Disease / Immunology
Shanchol is an oral, inactivated cholera vaccine that stimulates immune responses against Vibrio cholerae O1 and O139 antigens to prevent cholera infection.
Phase 2 pipeline
- Cholvax · Other
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- International Centre for Diarrhoeal Disease Research, Bangladesh portfolio CI brief
- International Centre for Diarrhoeal Disease Research, Bangladesh pipeline updates RSS
Frequently asked questions about International Centre for Diarrhoeal Disease Research, Bangladesh
What are International Centre for Diarrhoeal Disease Research, Bangladesh's marketed drugs?
Top marketed products include Bivalent OPV 2 week interval, Bivalent OPV 4 week interval, Fractional IPV( fIPV), Hepa-B, Hexavalent vaccine, Hypo-osmolar ORS.
What is International Centre for Diarrhoeal Disease Research, Bangladesh's pipeline?
International Centre for Diarrhoeal Disease Research, Bangladesh has 7 drugs in Phase 3, 1 in Phase 2, 1 in Phase 1. Late-stage candidates include Amylase resistant starch added ORS, Blood and adrenaline, Blood and Dopamine, Measles and Rubella (MR).
Related
- Bivalent OPV 2 week interval · Immunology
- Bivalent OPV 4 week interval
- Fractional IPV( fIPV) · Immunology / Infectious Disease
- Hepa-B · Immunology / Infectious Disease
- Hexavalent vaccine · Immunology
- Sector hub: All tracked pharma companies